Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control study
Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control study
To assess cancer incidence in the UK cystic fibrosis (CF) population and determine the associated risk factors, we undertook a nested case-control study of patients with CF, registered with the UK CF Registry. Each case with a first reported cancer between 1999 and 2017 was matched with up to 4 controls: by age (±2-years) and year of cancer diagnosis. Conditional logistic regressions were adjusted for sex, lung function (FEV
1%), CF related diabetes (CFRD), F508del status, transplant status, DIOS, gastro-oesophageal reflux disease, meconium ileus, Pseudomonas aeruginosa infection, pancreatic insufficiency, proton pump inhibitor (PPI) use, IV antibiotic days and BMI. Results: From 12,886 registered patients, 146 (1.1%) cases of malignancy were identified with 14.3% of cases occurring post solid organ transplant. Site of primary cancer was available for 98 patients: 22% were gastro-intestinal in origin (77% lower, 23% upper GI), 13% skin, 13% breast and 11% lymphomas/leukaemia. In univariable analysis, transplantation increased the odds of reporting any cancer by 2.46 times (95%CI: 1.3-4.6). CFRD also increased the odds of reporting any cancer (OR 2.35; CI: 1.37-4.0) and PPI use (OR 2.0; CI 1.28-3.19). In the multivariable models significant associations with CFRD and transplant remained, while PA infection, PPI use and being overweight showed increased, but statistically insignificant risks. The incidence of GI cancer was strongly associated with CFRD (OR=4.04; 1.47-11.1). Conclusions: We observed a high incidence of lower GI cancers in our cohort which was significantly affected by the presence of CFRD. Screening for gastrointestinal cancers could benefit patients at higher risk.
Breast, Cancer, Cystic fibrosis, Gastro-intestinal, Registry, Risk, Skin
Archangelidi, Olga
0ac00a72-1e2a-4bc4-9fad-105801545611
Cullinan, Paul
b5b2eb0a-9fb9-4d4b-af18-5109de92d742
Simmonds, Nicholas J.
24be5ea0-7d2c-47c7-bda7-66a14c851cd0
Mentzakis, Emmanouil
c0922185-18c7-49c2-a659-8ee6d89b5d74
Peckham, Daniel
e22cccc4-790e-445b-803e-9ade010384cf
Bilton, Diana
46bbb90e-5d96-4395-b708-455b9d906b54
Carr, Siobhán B.
dca7a189-1a70-42dc-8942-4b6552d74ffc
Archangelidi, Olga
0ac00a72-1e2a-4bc4-9fad-105801545611
Cullinan, Paul
b5b2eb0a-9fb9-4d4b-af18-5109de92d742
Simmonds, Nicholas J.
24be5ea0-7d2c-47c7-bda7-66a14c851cd0
Mentzakis, Emmanouil
c0922185-18c7-49c2-a659-8ee6d89b5d74
Peckham, Daniel
e22cccc4-790e-445b-803e-9ade010384cf
Bilton, Diana
46bbb90e-5d96-4395-b708-455b9d906b54
Carr, Siobhán B.
dca7a189-1a70-42dc-8942-4b6552d74ffc
Archangelidi, Olga, Cullinan, Paul, Simmonds, Nicholas J., Mentzakis, Emmanouil, Peckham, Daniel, Bilton, Diana and Carr, Siobhán B.
(2021)
Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control study.
Journal of Cystic Fibrosis.
(doi:10.1016/j.jcf.2021.07.004).
Abstract
To assess cancer incidence in the UK cystic fibrosis (CF) population and determine the associated risk factors, we undertook a nested case-control study of patients with CF, registered with the UK CF Registry. Each case with a first reported cancer between 1999 and 2017 was matched with up to 4 controls: by age (±2-years) and year of cancer diagnosis. Conditional logistic regressions were adjusted for sex, lung function (FEV
1%), CF related diabetes (CFRD), F508del status, transplant status, DIOS, gastro-oesophageal reflux disease, meconium ileus, Pseudomonas aeruginosa infection, pancreatic insufficiency, proton pump inhibitor (PPI) use, IV antibiotic days and BMI. Results: From 12,886 registered patients, 146 (1.1%) cases of malignancy were identified with 14.3% of cases occurring post solid organ transplant. Site of primary cancer was available for 98 patients: 22% were gastro-intestinal in origin (77% lower, 23% upper GI), 13% skin, 13% breast and 11% lymphomas/leukaemia. In univariable analysis, transplantation increased the odds of reporting any cancer by 2.46 times (95%CI: 1.3-4.6). CFRD also increased the odds of reporting any cancer (OR 2.35; CI: 1.37-4.0) and PPI use (OR 2.0; CI 1.28-3.19). In the multivariable models significant associations with CFRD and transplant remained, while PA infection, PPI use and being overweight showed increased, but statistically insignificant risks. The incidence of GI cancer was strongly associated with CFRD (OR=4.04; 1.47-11.1). Conclusions: We observed a high incidence of lower GI cancers in our cohort which was significantly affected by the presence of CFRD. Screening for gastrointestinal cancers could benefit patients at higher risk.
Text
Cancer_in_CF_JCF
- Accepted Manuscript
More information
Accepted/In Press date: 5 July 2021
e-pub ahead of print date: 1 August 2021
Keywords:
Breast, Cancer, Cystic fibrosis, Gastro-intestinal, Registry, Risk, Skin
Identifiers
Local EPrints ID: 453524
URI: http://eprints.soton.ac.uk/id/eprint/453524
ISSN: 1569-1993
PURE UUID: bdc2e38a-de49-457e-a506-fad762c2de8b
Catalogue record
Date deposited: 18 Jan 2022 18:13
Last modified: 17 Mar 2024 06:48
Export record
Altmetrics
Contributors
Author:
Olga Archangelidi
Author:
Paul Cullinan
Author:
Nicholas J. Simmonds
Author:
Daniel Peckham
Author:
Diana Bilton
Author:
Siobhán B. Carr
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics